Group One Trading’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-389,200
| Closed | -$1.9M | – | 7951 |
|
|
2025
Q1 | $1.9M | Buy |
389,200
+272,600
| +234% | +$1.64M | 0.01% | 1858 |
|
|
2024
Q4 | $972K | Buy |
116,600
+106,900
| +1,102% | +$934K | ﹤0.01% | 2601 |
|
|
2024
Q3 | $101K | Sell |
9,700
-14,690
| -60% | -$244K | ﹤0.01% | 4169 |
|
|
2024
Q2 | $480K | Buy |
24,390
+1,115
| +5% | +$22.3K | ﹤0.01% | 2600 |
|
|
2024
Q1 | $596K | Sell |
23,275
-40,150
| -63% | -$1.03M | ﹤0.01% | 2561 |
|
|
2023
Q4 | $1.75M | Buy |
63,425
+29,505
| +87% | +$1.8M | ﹤0.01% | 1980 |
|
|
2023
Q3 | $2.06M | Sell |
33,920
-450
| -1% | -$31.6K | 0.01% | 1620 |
|
|
2023
Q2 | $2.26M | Buy |
34,370
+32,875
| +2,199% | +$2.41M | 0.01% | 1595 |
|
|
2023
Q1 | $95.1K | Buy |
1,495
+585
| +64% | +$66.8K | ﹤0.01% | 4344 |
|
|
2022
Q4 | $126K | Sell |
910
-8,640
| -90% | -$1.22M | ﹤0.01% | 4230 |
|
|
2022
Q3 | $1.21M | Buy |
9,550
+4,625
| +94% | +$523K | ﹤0.01% | 2378 |
|
|
2022
Q2 | $408K | Buy |
4,925
+1,580
| +47% | +$123K | ﹤0.01% | 3617 |
|
|
2022
Q1 | $324K | Sell |
3,345
-7,835
| -70% | -$1.03M | ﹤0.01% | 4288 |
|
|
2021
Q4 | $2.23M | Sell |
11,180
-9,425
| -46% | -$2.22M | ﹤0.01% | 2481 |
|
|
2021
Q3 | $5.1M | Buy |
20,605
+2,679
| +15% | +$766K | 0.01% | 1663 |
|
|
2021
Q2 | $7.43M | Buy |
17,926
+363
| +2% | +$144K | 0.01% | 1332 |
|
|
2021
Q1 | $6.86M | Buy |
17,563
+8,531
| +94% | +$4.2M | 0.01% | 1238 |
|
|
2020
Q4 | $5.06M | Buy |
9,032
+1,158
| +15% | +$734K | 0.01% | 1268 |
|
|
2020
Q3 | $5.5M | Sell |
7,874
-742
| -9% | -$579K | 0.02% | 858 |
|
|
2020
Q2 | $6.81M | Sell |
8,616
-3,080
| -26% | -$2.32M | 0.03% | 612 |
|
|
2020
Q1 | $6.96M | Buy |
11,696
+6,910
| +144% | +$6.73M | 0.06% | 387 |
|
|
2019
Q4 | $5.44M | Buy |
4,786
+2,277
| +91% | +$2.48M | 0.04% | 634 |
|
|
2019
Q3 | $2.98M | Sell |
2,509
-5,396
| -68% | -$8.24M | 0.02% | 910 |
|
|
2019
Q2 | $13M | Buy |
7,905
+4,601
| +139% | +$7.96M | 0.12% | 172 |
|
|
2019
Q1 | $6.73M | Sell |
3,304
-3,798
| -53% | -$6.69M | 0.08% | 308 |
|
|
2018
Q4 | $9.13M | Sell |
7,102
-1,027
| -13% | -$1.58M | 0.08% | 279 |
|
|
2018
Q3 | $15.4M | Buy |
8,129
+949
| +13% | +$1.96M | 0.12% | 165 |
|
|
2018
Q2 | $14.6M | Buy |
7,180
+294
| +4% | +$670K | 0.12% | 163 |
|
|
2018
Q1 | $15.2M | Sell |
6,886
-6,516
| -49% | -$16.6M | 0.15% | 125 |
|
|
2017
Q4 | $30.9M | Buy |
13,402
+6,554
| +96% | +$13.3M | 0.22% | 76 |
|
|
2017
Q3 | $12.2M | Buy |
6,848
+865
| +14% | +$1.21M | 0.11% | 204 |
|
|
2017
Q2 | $8.14M | Sell |
5,983
-3,644
| -38% | -$4.4M | 0.08% | 275 |
|
|
2017
Q1 | $11.3M | Sell |
9,627
-648
| -6% | -$661K | 0.13% | 167 |
|
|
2016
Q4 | $8.21M | Buy |
10,275
+4,616
| +82% | +$3.67M | 0.08% | 280 |
|
|
2016
Q3 | $4.97M | Buy |
5,659
+1,598
| +39% | +$1.16M | 0.05% | 416 |
|
|
2016
Q2 | $2.28M | Sell |
4,061
-3,211
| -44% | -$1.82M | 0.03% | 750 |
|
|
2016
Q1 | $4M | Buy |
7,272
+617
| +9% | +$379K | 0.06% | 427 |
|
|
2015
Q4 | $5.54M | Buy |
6,655
+2,571
| +63% | +$2.57M | 0.07% | 330 |
|
|
2015
Q3 | $4.53M | Buy |
4,084
+1,498
| +58% | +$2.73M | 0.06% | 382 |
|
|
2015
Q2 | $5.64M | Buy |
2,586
+1,034
| +67% | +$2.11M | 0.08% | 283 |
|
|
2015
Q1 | $2.43M | Sell |
1,552
-401
| -21% | -$529K | 0.04% | 545 |
|
|
2014
Q4 | $2.32M | Buy |
1,953
+100
| +5% | +$66.8K | 0.04% | 570 |
|
|
2014
Q3 | $861K | Buy |
1,853
+1,143
| +161% | +$527K | 0.01% | 1211 |
|
|
2014
Q2 | $355K | Buy |
710
+401
| +130% | +$129K | 0.01% | 1928 |
|
|
2014
Q1 | $91K | Buy |
+309
| New | +$93.6K | ﹤0.01% | 3160 |
|
Other funds holding BLUE
Group One Trading's BLUE Position: Q2 2025 in Review
Group One Trading sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 21,693 shares — an estimated $106K sold.
Group One Trading first reported a position in BLUE in Q1 2014 and held it in 39 quarters. The position peaked at $8.62M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Group One Trading reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 21,693 bluebird bio shares in Q2 2025, an estimated $106K.
- Group One Trading first reported a position in bluebird bio in Q1 2014 and held it in 39 quarters.
- Group One Trading's bluebird bio position peaked at $8.62M in Q2 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.